Intraperitoneal chemotherapy is equally safe and effective in ovarian cancer patients with and without Germline BRCA1 or BRCA2 mutations
Year: 2019
Type: article
Source: Gynecologic Oncology
Authors: S. Jorge, A. Kay, K. Doll, B. Norquist, K. Pennington, R. Urban, E. Swisher, H. Gray
Institution: University of Washington
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2949964982